Primary Navigation for the CDC Website
CDC en Español
2006 Assisted Reproductive Technology (ART) Report: Appendix A


How to Interpret a Confidence Interval | Findings from Validation Visits for 2006 ART Data | Discrepancy Rates by Data Fields Selected for Validation

How to Interpret a Confidence Interval

What is a confidence interval?
Simply speaking, confidence intervals are a useful way to consider margin of error, a statistic often used in voter polls to indicate the range within which a value is likely to be correct (e.g., 30% of the voters favor a particular candidate with a margin of error of plus or minus 3.5%). Similarly, in this report, confidence intervals are used to provide a range that we can be quite confident contains the success rate for a particular clinic during a particular time.

Why do we need to consider confidence intervals if we already know the exact success rates for each clinic in 2006?
No success rate or statistic is absolute. Suppose a clinic performed 100 cycles among women younger than 35 in 2006 and had a success rate of 20% with a confidence interval of 12%–28%. The 20% success rate tells us that the average chance of success for women younger than 35 treated at this clinic in 2006 was 20%. How likely is it that the clinic could repeat this performance? For example, if the same clinic performed another 100 cycles under similar clinical conditions on women with similar characteristics, would the success rate again be 20%? The confidence interval tells us that the success rate would likely fall between 12% and 28%.

Why does the size of the confidence interval vary for different clinics?
The size of the confidence interval gives us a realistic sense of how secure we feel about the success rate. If the clinic had performed only 20 cycles instead of 100 among women younger than 35 and still had a 20% success rate (4 successes out of 20 cycles), the confidence interval would be much larger (between 3% and 37%) because the success or failure of each individual cycle would be more significant. For example, if just one more cycle had resulted in a live birth, the success rate would have been substantially higher — 25%, or 5 successes out of 20 cycles. Likewise, if just one more cycle had not been successful, the success rate would have been substantially lower — 15%, or 3 out of 20 cycles. Compare this scenario to the original example of the clinic that performed 100 cycles and had a 20% success rate. If just one more cycle had resulted in a live birth, the success rate would have changed only slightly, from 20% to 21%, and if one more cycle had not been successful, the success rate would have fallen to only 19%. Thus, our confidence in a 20% success rate depends on how many cycles were performed.

Why should confidence intervals be considered when success rates from different clinics are being compared?
Confidence intervals should be considered because success rates can be misleading. For example, if Clinic A performs 20 cycles in a year and 8 cycles result in a live birth, its live birth rate would be 40%. If Clinic B performs 600 cycles and 180 result in a live birth, the percentage of cycles that resulted in a live birth would be 30%. We might be tempted to say that Clinic A has a better success rate than Clinic B. However, because Clinic A performed few cycles, its success rate would have a wide 95% confidence interval of 18.5%–61.5%. On the other hand, because Clinic B performed a large number of cycles, its success rate would have a relatively narrow confidence interval of 26.2%–33.8%. Thus, Clinic A could have a rate as low as 18.5% and Clinic B could have a rate as high as 33.8% if each clinic repeated its treatment with similar patients under similar clinical conditions. Moreover, Clinic B’s rate is much more likely to be reliable because the size of its confidence interval is much smaller than Clinic A’s.

Even though one clinic’s success rate may appear higher than another’s based on the confidence intervals, these confidence intervals are only one indication that the success rate may be better. Other factors also must be considered when comparing rates from two clinics. For example, some clinics see more than the average number of patients with difficult infertility problems, whereas others discourage patients with a low probability of success.  For more information see important factors to consider when using the tables to assess a clinic

Findings from Validation Visits for 2006 ART Data

Clinic site visits for validation of 2006 ART data were conducted April through June 2008. During each visit, data reported by the clinic were compared with information recorded in patients’ charts. Records for 1,644 cycles at 35 clinics were randomly selected for validation. These selected
cycles included 533 cycles that resulted in a pregnancy and 434 cycles that resulted in a live-birth delivery.

Discrepancy rates are listed below for key data items that were validated for each of the selected cycles. Review of the discrepancies indicated that in the majority of cases, the error did not affect the success rates (included in the national summary table and in the individual clinic tables). In addition to fully validating data for the randomly selected 1,644 cycles, during each visit the validation team also reviewed the documentation for every live birth that had been reported to CDC. There were no cases found in which a live birth had been reported erroneously. In all, validation indicated that the clinic success rates presented in this report are valid.

Discrepancy Rates by Data Fields Selected for Validation

Data Field Name Discrepancy
Rate*
(Confidence Interval†)
Comments
Patient date of birth 2.0%
(1.4–2.6)
Nearly one-third of the discrepancies resulted in a change of Age Group Category (see Clinic Summary Table classification) and differed only by one age category.
Diagnosis of infertility 16.7%
(13.2–20.2)
For approximately one-third of the total 283 discrepancies, multiple causes of infertility were found in the patient’s chart, but only a single cause was reported. For 44 discrepancies, multiple causes were reported but only a single cause was found in the patient’s chart.
Type of ART (i.e., fresh vs. frozen; donor vs. nondonor) <1%  

 

Use of ICSI 1.6%
(0.8–2.3)

For about three-fourths of these discrepancies, use of ICSI was indicated in the patient’s chart but was not reported.

Number of embryos
transferred
1.6%
(0.6–2.7)
Nearly all discrepancies differed by one or two embryos.
Outcome of ART treatment (i.e., pregnant vs. not pregnant) <1%  
Number of fetal hearts on ultrasound 1.3%
(0.5–2.1)
Of the discrepancies, six cases resulted in a change in categorization of single- versus multiple-fetus pregnancy.
Pregnancy outcome
(i.e., miscarriage, stillbirth, and live birth)
1.1%
(0.5–1.8)
In most of these discrepancies, there was no information on pregnancy outcome in the patient’s chart, or spontaneous abortion was reported as induced abortion, or vice versa.
Number of infants born 1.1%
(0.7–1.4)
In more than half of the discrepancies, there was no information on the number of infants born in the patient’s chart. In one case, a twin delivery was recorded in the patient’s chart when a singleton delivery was reported.
Cycle cancelation <1%

 

Notes: ART = assisted reproductive technology; ICSI = intracytoplasmic sperm injection.

* Discrepancy rates estimate the proportion of all treatment cycles with differences for a particular data item. The discrepancy-rate calculations weight the data from validated cycles to reflect the overall number of cycles performed at each clinic. Thus, findings from larger clinical practices were weighted more heavily than findings from smaller practices.

† This table shows a range, called the 95% confidence interval, that conveys the reliability of the discrepancy rate. For a more information, see explanation of confidence intervals.


Selected Resources

Previous ART Reports

Implementation of the Fertility Clinic Success Rate and Certification Act of 1992

Page last reviewed: 12/3/08
Page last modified: 12/3/08
Content source: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion

rectangle border
ART label image
bulletbullet Find a Clinic and National Summary
bulletbullet Download Report

bullet 2006 Report Home
bullet Acknowledgements
bullet Preface
bullet Commonly Asked Questions
bullet Introduction to the National Report
bullet Overview
bullet Fresh Nondonor Eggs or Embryos
bullet Frozen Nondonor Embryos
bullet Donor Eggs
bullet Trends, 1996–2006
bullet Introduction to Fertility Clinic Tables
bullet Sample Clinic Table
bullet How to Read a Fertility Clinic Table
bullet Confidence Intervals and Validation Findings
bullet Glossary of Terms
bullet Reporting Clinics
bullet Non-Reporting Clinics
bullet National Consumer Organizations
rectangle border

Reproductive Health related resources
bullet Reproductive Health Home
bullet Data and Statistics
bullet Publications and Products
bullet

Glossary

bullet Related Links

bullet Adolescent Reproductive Health
bullet Assisted Reproductive Technology
bullet Global Reproductive Health
bullet Maternal and Infant Health Research
bullet Refugee Reproductive Health
bullet Sudden Infant Death Syndrome
bullet Unintended Pregnancy
bullet Women's Reproductive Health

bullet Division of Reproductive Health

 
Contact Info
CDC/DRH
4770 Buford Hwy, NE
MS K-20
Atlanta, GA 30341-3717

Phone number
770-488-5200

bullet Contact Us

divider
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435
USAGov LogoDHHS Department of Health
and Human Services